Brief: Onward Medical Accepted To FDA Program For Development Of ARC-BCI System
11/03/2024 07:17
March 11 (Reuters) - Onward Medical NV ONWD.BR :
* ONWARD MEDICAL ACCEPTED TO NEW US FDA TAP PROGRAM FOR
DEVELOPMENT OF ITS ARC-BC SYSTEM
* ACCEPTANCE FOLLOWS ONWARD MEDICAL'S ANNOUNCEMENT LAST WEEK
THAT
ITS INVESTIGATIONAL ARC-BCI SYSTEM WAS AWARDED FDA BREAKTHROUGH
DEVICE DESIGNATION (BDD)
Source text for Eikon: urn:newsml:reuters.com:*:nGNE3px300
Further company coverage: ONWD.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587785110;))
Recent news on ONWARD Medical
See all newsBrief: Onward Medical Primary ABB Final Deal Size Was C.Eur 50m / 11.3m Shares, Says Bookrunner
Brief: Ottobock Invests EUR 10 Million In Onward Medical
Brief: Bookrunner Says Onward Medical Primary ABB Books Covered, Further Guidance To Follow
Brief: ONWARD Medical Receives FDA De Novo Classification
Brief: Onward Medical Says Receives FDA De Novo Classification And US Market Authorization For ARC-EX System